Speakers

Sort by
Newest
Trending
1-30 of 33
Filter
Blair Curless
Clinical Pharmacist at Phoebe Putney Health System
absorption (pharmacology), advertising, analgesic, anti-inflammatory, aphria (company), bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, class action, coffee, cosmetics, damages, dietary supplement, distribution (marketing), doctor of pharmacy, dose (biochemistry), drug, euphoria, false advertising, federal trade commission, flavor, food, food and drug administration, hemp, interleukin 17, kool-aid, law, lawsuit, ligand (biochemistry), marketplace, medical cannabis, medication, mountain dew, nestea, new drug application, nonsteroidal anti-inflammatory drug, novel food, opioid, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, pricing, product testing, recycling, regulatory compliance, retail, route of administration, shelf life, social media, soft drink, sublingual administration, tea, tetrahydrocannabinol, tetrahydrocannabivarin, toast (honor), topical medication
Najifa Choudhury
Ambulatory Care Pharmacist at PACE SEMI
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis (drug), cannabis edible, certificate of analysis, clinical trial, cytochrome p450, doctor of pharmacy, dose (biochemistry), drug interaction, drug overdose, euphoria, geriatrics, grapefruit–drug interactions, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, opioid, over-the-counter drug, oxycodone/paracetamol, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, prothrombin time, pulmonary embolism, route of administration, signal transduction, stroke, sublingual administration, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Cohin Kakar
Chief Marketing Officer at The Anthos Group
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, appetite, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, certificate of analysis, chemotherapy, clinical trial, cytochrome p450, dementia, doctor of pharmacy, dose (biochemistry), drug development, drug interaction, drug overdose, euphoria, fibromyalgia, food and drug administration, geriatrics, grapefruit–drug interactions, headache, inflammation, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, opioid epidemic in the united states, over-the-counter drug, oxycodone/paracetamol, personalized medicine, pharmaceutical formulation, pharmacogenomics, pharmacology, pharmacy, pharmacy school, placebo, prothrombin time, pulmonary embolism, route of administration, sensitivity and specificity, signal transduction, stroke, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Lola O Ohonba
Certified Medical Cannabist Specialist at WCI Health
absorption (pharmacology), alternative medicine, analgesic, anti-inflammatory, anti-predator adaptation, antidepressant, anxiolytic, appetite, bioavailability, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, cannabis industry, chemical substance, coffee, coffee bean, coffeehouse, democratic party (united states), doctor of pharmacy, dose (biochemistry), entourage effect, euphoria, food, food and drug administration, gerrymandering, interleukin 17, ligand (biochemistry), major depressive disorder, mechanism of action, medical cannabis, medication, neuroplasticity, neurotransmitter, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, pain, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, red bull, route of administration, sense, serotonin, solvent, starbucks, sublingual administration, swing state, tetrahydrocannabinol, tetrahydrocannabivarin, topical medication
Joseph Friedman
Consultant, National Speaker, Medical Cannabis Pharmacist
absorption (pharmacology), analgesic, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, cannabis strain, clinical trial, delta-8-tetrahydrocannabinol, doctor of pharmacy, dose (biochemistry), euphoria, first pass effect, high-performance liquid chromatography, institutional review board, interleukin 17, ligand (biochemistry), lipophilicity, mass spectrometry, medication, natural product, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, pharmaceutical formulation, pharmacokinetics, pharmacology, pharmacy, pharmacy school, route of administration, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, topical medication, waters corporation
Israel Garcia
Director Of Chemistry at Bayou City Hemp Company
bioavailability, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, emulsion, endocannabinoid system, food and drug administration, health, human, ibuprofen, memory, omega-3 fatty acid, omega-6 fatty acid, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, rapid eye movement sleep, route of administration, shelf life, sleep, solution, tablet (pharmacy), tetrahydrocannabinol, transparency and translucency
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Mike Sandoval
President at Sante Laboratories
accuracy and precision, analytical chemistry, aspergillosis, bank, bioavailability, brand, breakfast, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemical substance, chemistry, competition, consumer protection, conversation, crystallization, cytochrome p450, diclofenac, dietary supplement, distillation, dose (biochemistry), dream, drug development, due diligence, electronic cigarette, emulsion, endocannabinoid system, experiment, expert, expungement, food and drug administration, frosted mini-wheats, health, human, humidity, ibuprofen, immunodeficiency, infection, information, insurance, investor, laboratory, loan, market (economics), medical cannabis, memory, mold, money, mycotoxin, occupational safety and health, omega-3 fatty acid, omega-6 fatty acid, paracetamol, petroleum, ph meter, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, rapid eye movement sleep, reason, regulatory compliance, route of administration, safety, scientific method, sesame, shelf life, sleep, solution, stove, tablet (pharmacy), technology, temperature, tetrahydrocannabinol, the matrix, traceability, tractor, transparency and translucency, treaty, understanding
Adam Abodeely
Board Certified Surgeon & CEO-Founder at ReserveMD
adoption, allosteric modulator, alternative medicine, anesthesia, anticoagulant, antihypertensive drug, appetite, audit, background check, bank, benzodiazepine, best practice, bioavailability, bleeding, bloating, blood sugar level, board certification, brand, breathing, budtender, c-reactive protein, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis sativa, carbohydrate, central processing unit, charlotte's web (cannabis), chemotherapy, chemotherapy-induced nausea and vomiting, clinical trial, commerce clause, controlled substances act, craft brewery and microbrewery, crohn's disease, dementia, depression (mood), diarrhea, dietary supplement, disease, dose (biochemistry), drug, drug development, drug overdose, due diligence, edema, emergency department, endocannabinoid system, entourage effect, fda food safety modernization act, fda warning letter, fibromyalgia, flavonoid, food, food and drug administration, food safety, foodborne illness, gastrointestinal disease, gastroparesis, general surgery, good manufacturing practice, gut–brain axis, headache, heartburn, hemp, hemp oil, heroin, homeostasis, ibuprofen, ileostomy, immune system, indication (medicine), inflammation, inflammatory bowel disease, inhaler, intestinal permeability, iso 9000, lemon, lobbying, lung volumes, macrophage, medical cannabis, medical prescription, medication, mind, morphine, nanotechnology, nausea, neurology, neuron, neurosurgery, neurotransmitter, nicotine, nsf international, nutraceutical, opiate, opioid, opioid epidemic in the united states, opioid overdose, over-the-counter drug, oxycodone, oxycodone/paracetamol, pain, pain management, pathology, patient, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, pharmacy, physician, placebo, placebo-controlled study, polypharmacy, prescription drug, psychoactive drug, quality management system, reason, regulatory compliance, rhabdomyosarcoma, risk, route of administration, safety, scientific method, sensitivity and specificity, serotonin, serotonin syndrome, signal transduction, spasticities, stress (biology), surgery, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, therapeutic index, therapy, toxicity, ulcerative colitis, understanding, verification and validation, warfarin, water
Charles Piermarini
CEO at Restorative CBD
absorption (pharmacology), adoption, allosteric regulation, anti-inflammatory, anticoagulant, anticonvulsant, antiviral drug, benzodiazepine, bioavailability, breathing, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), certificate of analysis, clinical trial, coronavirus disease 2019, cytochrome p450, dietary supplement, dose (biochemistry), drug, drug interaction, drug overdose, flax, geriatrics, grapefruit–drug interactions, infection, inhaler, insomnia, ligand (biochemistry), lung volumes, medical cannabis, medication, melatonin, nanotechnology, omega-3 fatty acid, omega-6 fatty acid, opioid, over-the-counter drug, oxycodone/paracetamol, pain, patient, pharmaceutical industry, pharmacology, pharmacy, prothrombin time, pulmonary embolism, risk, route of administration, sense, serotonin, serotonin syndrome, signal transduction, sleep disorder, stroke, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, warfarin
Daniel Yazbeck
Founder at Yazbeck Investment Group
adoption, bioavailability, breathing, budtender, cannabidiol, cannabinoid, cannabis (drug), dietary supplement, dose (biochemistry), drug, inhaler, lung volumes, medical cannabis, medication, nanotechnology, pain, patient, pharmaceutical industry, risk, route of administration, serotonin, serotonin syndrome, terpene, tetrahydrocannabinol
Lynn Marie Morski
Medical Director at WayofLeaf
adoption, behavior, bioavailability, brand, breathing, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), commodity, dietary supplement, dose (biochemistry), drug, electronic cigarette, entourage effect, farmer, genetically modified food, hemp, herbicide, inhaler, insomnia, lung volumes, medical cannabis, medication, nanotechnology, nsf international, organic certification, pain, patient, pharmaceutical industry, price, risk, route of administration, serotonin, serotonin syndrome, solution, terpene, tetrahydrocannabinol, tobacco, warren buffett
Randy Fink
Physician, Medical Director at Miami Center of Excellence, LLC
alternative medicine, anesthesia, antihypertensive drug, anxiety, arm, aromatherapy, bank, bioidentical hormone replacement therapy, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, cannabis sativa, clinical trial, crohn's disease, crop insurance, curriculum, depression (mood), diarrhea, dose (biochemistry), endocannabinoid system, entourage effect, erection, evidence-based medicine, finance, food and drug administration, gastrointestinal disease, general surgery, gums, hemp, human sexual activity, ileostomy, inflammatory bowel disease, libido, medical cannabis, medical prescription, medication, mind, organized crime, orgasm, pain management, payment, pharmaceutical industry, pharmacology, pharmacy, placebo-controlled study, prescription drug, psychoactive drug, retail, route of administration, tadalafil, terminal illness, tetrahydrocannabinol, therapeutic index, transgender hormone therapy (male-to-female), ulcerative colitis
Carlton Bone
Founder at Upward Cannabis Kitchen
adolescence, alternative medicine, anesthesia, antibiotic, anticoagulant, anticonvulsant, antifungal, antihypertensive drug, appetite, aromatherapy, bank, bicycle, biotechnology, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinoids, cannabis, cannabis (drug), cannabis indica, certificate of analysis, chemotherapy, clinical trial, concept, crohn's disease, crop insurance, curriculum, curveball, cvs pharmacy, dementia, depression (mood), diarrhea, dose (biochemistry), drink, drug development, endocannabinoid system, engineer, entourage effect, evidence-based medicine, family medicine, fibromyalgia, finance, food and drug administration, gastrointestinal disease, general surgery, good manufacturing practice, headache, ileostomy, inflammation, inflammatory bowel disease, market (economics), medical cannabis, medical prescription, medication, neurology, nutraceutical, opioid, opioid epidemic in the united states, organized crime, over-the-counter drug, pain management, payment, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacology, pharmacy, placebo, placebo-controlled study, prescription drug, psychoactive drug, race (human categorization), reverse engineering, route of administration, sense, sensitivity and specificity, slider (baseball), stroke, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, therapeutic index, thrombus, ulcerative colitis, washington (state)
Jerome Julian Grove
Co-Founder at The Physician's Choice CBD
alprazolam, alternative medicine, amitriptyline, analgesic, anesthesia, antihypertensive drug, arthritis, benzodiazepine, benzodiazepine withdrawal syndrome, buprenorphine, buprenorphine/naloxone, cancer, cannabinoid, carisoprodol, chiropractic, complex regional pain syndrome, crohn's disease, cyclobenzaprine, depression (mood), diabetic neuropathy, diarrhea, diazepam, diclofenac, dose (biochemistry), entourage effect, fentanyl, forecoxa, gabapentin, gastrointestinal disease, general surgery, harm reduction, heroin, ibuprofen, ileostomy, inflammatory bowel disease, lorazepam, medical cannabis, medical prescription, medication, meloxicam, methadone, muscle relaxant, naproxen, opiate, opioid, opioid epidemic in the united states, opioid use disorder, over-the-counter drug, oxycodone/paracetamol, pain management, paracetamol, paresthesia, peripheral neuropathies, peripheral neuropathy, pharmacology, pregabalin, psychoactive drug, rheumatology, route of administration, substance dependence, systemic lupus erythematosus, tapenade, terminal illness, tetrahydrocannabinol, therapeutic index, tramadol, ulcerative colitis
Karyemaitre Aliffe
Charlotte's Web
addiction, alternative medicine, analgesic, anesthesia, antihypertensive drug, benzodiazepine, big data, brand, caffeine, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis indica, cannabis sativa, circulatory system, craft brewery and microbrewery, crohn's disease, customer, data, depression (mood), diarrhea, dose (biochemistry), drug, entourage effect, food, gastrointestinal disease, general surgery, goal, herb, herbal medicine, heroin, ileostomy, inflammatory bowel disease, major depressive disorder, mechanism of action, medical cannabis, medical prescription, medication, microwave, mirror, molecule, mood (psychology), mood disorder, natural product, nutrient, pain, pharmacology, phytochemistry, placebo, psychoactive drug, recreational drug use, route of administration, scientific method, sedative, social rejection, stress (biology), substance abuse, substance dependence, taste, terminal illness, tetrahydrocannabinol, tetraodontidae, thalidomide, therapeutic index, ulcerative colitis, vitamin, water, whole foods market, wine, wood
William Fisher
Board Chairman at Diverse Biotech
appetite, aspirin, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), chemotherapy, clinical trial, dementia, dietary supplement, direct-to-consumer advertising, dose (biochemistry), drug development, endocannabinoid system, fibromyalgia, first, pass effect, food and drug administration, gastrointestinal tract, headache, hemp, in vitro, inflammation, intravenous therapy, micro-encapsulation, nanoparticle, nutraceutical, opioid epidemic in the united states, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacology, pharmacy, placebo, route of administration, sensitivity and specificity, steve jobs, synthetic cannabinoids, tetrahydrocannabinol, toxicity
Todd Griffin
Chief Technical Officer at G2 Analytical
aspirin, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), dietary supplement, direct-to-consumer advertising, endocannabinoid system, first, pass effect, food and drug administration, gastrointestinal tract, hemp, in vitro, intravenous therapy, micro-encapsulation, nanoparticle, nutraceutical, pharmaceutical industry, pharmacology, route of administration, steve jobs, tetrahydrocannabinol, toxicity
Daniel Sliva
CSO & Founder at DSTest Laboratories
allosteric regulation, anti-inflammatory, antiviral drug, aspirin, assay, attention, bioavailability, biology, blinded experiment, book, bootleg recording, brand, brand loyalty, breast cancer, cancer, cannabidiol, cannabidiol is, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cardiovascular disease, cell signaling, chemical substance, chemistry, chromatography, chronic pain, cigarette, clinical trial, clinicaltrials.gov, coffee, coffee bean, common sense, coronavirus disease 2019, crisis management, diesel fuel, dietary supplement, direct-to-consumer advertising, distillation, dose (biochemistry), drug, drug test, end-user, endocannabinoid system, experiment, first, pass effect, flax, food, food and drug administration, fraud, gastrointestinal tract, germination, good manufacturing practice, green tea, hemp, hepatotoxicity, high-performance liquid chromatography, hospital, ibuprofen, in vitro, infection, inflammation, innovation, insomnia, intravenous therapy, iso/iec 17025, knowledge, laboratory, ligand (biochemistry), lipid, marketplace, medication, melatonin, micro-encapsulation, mining, molecule, nabiximols, nanoparticle, national institutes of health, nutraceutical, occupational safety and health, omega-3 fatty acid, omega-6 fatty acid, organ transplantation, osteoarthritis, packaging and labeling, pain, paracetamol, peripheral neuropathy, petroleum, pharmaceutical industry, pharmacokinetics, pharmacology, psychoactive drug, randomized controlled trial, reason, receptor (biochemistry), recycling, reliability engineering, research, right to know, risk, route of administration, sense, serotonin, sleep disorder, social supports, steam distillation, steve jobs, supercritical fluid, taste, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, the end-user, thin-layer chromatography, toxicity, vitamin, warranty, waste, water, women's health
Jessica Barnes
CEO & Co-founder at 20Lighter Program
aspirin, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), dietary supplement, direct-to-consumer advertising, endocannabinoid system, first, pass effect, food and drug administration, gastrointestinal tract, hemp, in vitro, intravenous therapy, micro-encapsulation, nanoparticle, nutraceutical, pharmaceutical industry, pharmacology, route of administration, steve jobs, tetrahydrocannabinol, toxicity
Shari Campbell
Lead Chemist at Kaycha Labs
aspirin, bioavailability, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoids, cannabis, cannabis (drug), certified reference materials, clinical trial, dairy, dietary supplement, direct-to-consumer advertising, endocannabinoid system, first, pass effect, food, food and drug administration, gastrointestinal tract, good manufacturing practice, hemp, high-performance liquid chromatography, in vitro, intravenous therapy, medical device, micro-encapsulation, nanoparticle, nuclear magnetic resonance, nutraceutical, packaging and labeling, pharmaceutical industry, pharmacology, protocol (science), quality assurance, quality management system, research, retail, route of administration, shelf life, standard deviation, steve jobs, tetrahydrocannabinol, toxicity, uncertainty
Jennah Noegel
Chief Operating Officer at Gruene Cross Health & Wellness
absorption (pharmacology), allergy, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), chronic stress, cortisol, crohn's disease, cytokine, dose (biochemistry), food allergy, gastrointestinal tract, grapefruit–drug interactions, herbal medicine, hypertension, opioid, pain, route of administration, stress (biology), tetrahydrocannabinol, therapy, tumor necrosis factor-alpha
Luis Enrique Weyback
Founder and President at Doctor Jane
absorption (pharmacology), allergy, alzheimer's disease, bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), carbohydrate, chronic stress, chronic traumatic encephalopathy, clinical trial, concussion, cortisol, cortisone, crohn's disease, cytokine, dietary supplement, disease, doping in sport, dose (biochemistry), drug overdose, emergency department, fluid replacement, food, food allergy, gastrointestinal tract, grapefruit–drug interactions, healing, heart, herbal medicine, heroin, hypertension, ibuprofen, inflammation, medical cannabis, medication, medicine, naproxen, neurology, neurosurgery, nicotine, nonsteroidal anti-inflammatory drug, opioid, opioid overdose, pain, pharmaceutical industry, pharmacokinetics, reactive oxygen species, route of administration, stress (biology), surgery, tetrahydrocannabinol, therapy, trpv1, tumor necrosis factor-alpha, vasodilation, wound
Roger Bryant
Owner at Evolve Distributions
absorption (pharmacology), allergy, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), chronic stress, cortisol, crohn's disease, cytokine, dose (biochemistry), food allergy, gastrointestinal tract, grapefruit–drug interactions, herbal medicine, hypertension, opioid, pain, route of administration, stress (biology), tetrahydrocannabinol, therapy, tumor necrosis factor-alpha
Keiko Beatie
Director of Education & Programming Coral Cove Cannabis Jamaica Holistic Ayurvedic Chinese Medicine at Green Wave Relations
absorption (pharmacology), acne, aesthetics, agriculture, allergy, american broadcasting company, anxiety, anxiety disorder, arthritis, attention, ayurveda, belief, bioavailability, brand, broadcast syndication, cake, cancer, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, cannabis strain, cbs, certificate of analysis, chemical peel, china, chinese herbology, chronic pain, chronic stress, clinical trial, cortisol, cosmetics, crohn's disease, cytokine, dementia, design, dietary supplement, dose (biochemistry), drug, drug overdose, drug rehabilitation, endocannabinoid system, ethanol, federal aviation administration, flower, food, food allergy, food and drug administration, fox broadcasting company, gastrointestinal tract, good manufacturing practice, grapefruit–drug interactions, grocery store, haircare, health care, heat, hemp, herbal medicine, hypertension, law, lawyer, lotion, medical cannabis, medication, medicine, medium-chain triglyceride, mental disorder, mood (psychology), nbc, news, nutraceutical, opiate, opioid, organic certification, osteoarthritis, packaging and labeling, packaging, and labeling, pain, pain management, percentage, pesticide, pharmaceutical industry, prescription drug, pricing, psilocybin, qr code, reputation, retail, route of administration, runway, seed, separation anxiety disorder, shelf life, soap, solubility, stress (biology), substance dependence, tablet (pharmacy), tea, tetrahydrocannabinol, textbook, therapy, traditional chinese medicine, tumor necrosis factor-alpha, united states department of agriculture, veterinarian
Rob Streisfeld
CEO at BeyondBrands
absorption (pharmacology), allergy, alternative medicine, appetite, bioavailability, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis indica, chemotherapy, chronic stress, cortisol, crohn's disease, cytokine, dose (biochemistry), endocannabinoid system, endocrinology, epilepsy, food allergy, food and drug administration, gastrointestinal tract, grapefruit–drug interactions, herbal medicine, hormone, hypertension, obesity, opioid, pain, probiotic, route of administration, selective serotonin reuptake inhibitor, sleep, stress (biology), synthetic cannabinoids, tetrahydrocannabinol, therapy, traditional chinese medicine, tumor necrosis factor-alpha, vitamin c, well-being
Sytze Elzinga
Chief Science Officer at The Werc Shop
aromaticity, cannabidiol, cannabinoid, cannabis, chromium, dietary supplement, dose (biochemistry), entourage effect, epilepsy, food, food and drug administration, good manufacturing practice, hemp, herbal medicine, ligand (biochemistry), limonene, medication, medicine, mind, pharmaceutical industry, route of administration, synergy, tetrahydrocannabinol, time, traditional chinese medicine
Tristan Watkins
Chief Science Officer (CSO) at LucidMood
23andme, adolescence, aromatherapy, aromaticity, bicycle, biotechnology, brand, budtender, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis indica, cannabis sativa, chromium, concept, creativity, curveball, dietary supplement, disease, dose (biochemistry), drink, electronic cigarette, engineer, entourage effect, epilepsy, food, food and drug administration, genetics, good manufacturing practice, hemp, herbal medicine, inflammation, insomnia, ligand (biochemistry), limonene, market (economics), medical cannabis, medication, medicine, memory, mind, pharmaceutical industry, placebo, questionnaire, race (human categorization), relaxation (psychology), reverse engineering, route of administration, science, sedative, sense, slider (baseball), synergy, terpene, tetrahydrocannabinol, time, traditional chinese medicine, washington (state), zolpidem
Gabriela Villacorta
Founder at Sneha
aromaticity, cannabidiol, cannabinoid, cannabis, chromium, dietary supplement, dose (biochemistry), entourage effect, epilepsy, food, food and drug administration, good manufacturing practice, hemp, herbal medicine, ligand (biochemistry), limonene, medication, medicine, mind, pharmaceutical industry, route of administration, synergy, tetrahydrocannabinol, time, traditional chinese medicine
1 2